Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma

ConclusionAfter the administration of omidenepag isopropyl, IOP in patients with NTG decreased within 3 years, visual fields were maintained, and safety was satisfactory. Thus, omidenepag isopropyl can be used as the first-line treatment for patients with NTG.
Source: Japanese Journal of Ophthalmology - Category: Opthalmology Source Type: research